Syngene International Ltd
Bommasandra Industrial Estate - Phase-IV
Bangalore
Karnataka
56099
Website: http://syngeneintl.com/
Email: bdc@syngeneintl.com
About Syngene International Ltd
Syngene is a cutting-edge contract research and manufacturing organization, which aids in R&D programs from lead generation to clinical supplies. Our multi-dimensional skills in integrated drug development and discovery include capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development along with clinical development services.
3 articles about Syngene International Ltd
-
Panbela Announces Issuance of New Patent in China for Claims of a Novel Process for the Production of SBP-101Patent developed in collaboration with Syngene International Ltd.
9/26/2023
Panbela today announced an Issue Notification for the Chinese patent 201980010826.7 titled “METHODS FOR PRODUCING (6S,15S)-3,8,13,18- TETRAAZAICOSANE-6,15-DIOL”.
-
Panbela Announces Issuance of New Patent in Europe for Claims of a Novel Process for the Production of SBP-101
8/14/2023
Panbela Therapeutics, Inc. today announced an Issue Notification for the European patent 2019213664 titled “METHODS FOR PRODUCING (6S,15S)-3,8,13,18- TETRAAZAICOSANE-6,15-DIOL”.
-
Artelo Biosciences Enters Into Global R&D Partnership With Syngene International And Aptus Clinical For The Clinical Development Of ART27.13 In Oncology
6/12/2018
Artelo Biosciences, Inc. announced that it has entered into a global research and development partnership with Syngene International Ltd.